|
[Related PubMed/MEDLINE] Total Number of Papers: 108
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: PHY |
Long Form |
: physostigmine |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2021 |
Effects of Increased Central Cholinergic Activity on the Metabolic Challenge Induced by Submaximal Exercise in Rats: Adrenomedullary Secretion Influences. |
FFAs, i.c.v, sham-SAL |
2 |
2021 |
The Carbamate, Physostigmine does not Impair Axonal Transport in Rat Cortical Neurons. |
AChEIs, AXT, DFP, GWI, OPs |
3 |
2019 |
Cholinergic rescue of neurocognitive insult following third-trimester equivalent alcohol exposure in rats. |
CPFE, dHPC, IEGs, mPFC, PD, SAL, SI, vHPC |
4 |
2018 |
Central cholinergic activation induces greater thermoregulatory and cardiovascular responses in spontaneously hypertensive than in normotensive rats. |
HR, SAP, SHRs |
5 |
2018 |
The Neuroinflammatory Phenotype in a Mouse Model of Gulf War Illness is Unrelated to Brain Regional Levels of Acetylcholine as Measured by Quantitative HILIC-UPLC-MS/MS. |
ACh, AChEIs, CORT, CPO, CTX, DFP, GW, GWI, HIP, MS/MS, STR |
6 |
2018 |
Therapeutic effects of physostigmine during systemic inflammation. |
LPS |
7 |
2017 |
Corticosterone primes the neuroinflammatory response to Gulf War Illness-relevant organophosphates independently of acetylcholinesterase inhibition. |
AChE, CORT, CPO, DFP, GWI, PB, STAT3 |
8 |
2017 |
N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin. |
AD, NAC, STZ |
9 |
2016 |
[Anti-inflammatory effect of acetylcholine on lipopolysaccharide induced inflammatory response of alveolar macrophages]. |
ACh, AChE, ELISA, LPS, TNF-alpha |
10 |
2015 |
The dynamics of physical exercise-induced increases in thalamic and abdominal temperatures are modified by central cholinergic stimulation. |
T thal, VEH |
11 |
2013 |
PET imaging of acetylcholinesterase inhibitor-induced effects on alpha4beta2 nicotinic acetylcholine receptor binding. |
ACh, AChEIs, GAL, nAChR |
12 |
2013 |
[Involvement of cross interaction between central cholinergic and histaminergic systems in the nucleus tractus solitarius in regulating carotid sinus baroreceptor reflex]. |
CHL, CIM, CSR, HA, HEX, i.c.v, ISP, MAP, NTS, PRZ |
13 |
2012 |
Acetylcholinesterase inhibition interacts with training to reverse spatial learning deficits after cortical impact injury. |
AChE, BBB, TBI, TBI-PHY3.2, WM1 |
14 |
2012 |
The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam. |
AChE, CED, DZP, NMDA |
15 |
2011 |
Possible role of cholinesterase inhibitors on memory consolidation following hypobaric hypoxia of rats. |
AMS, GAL, HA, HBH, MWM |
16 |
2010 |
Cholinesterase inhibitors ameliorate spatial learning deficits in rats following hypobaric hypoxia. |
ACh, AChE, AChEIs, GAL, HA, HBH, MWM |
17 |
2010 |
Sinoaortic denervation prevents enhanced heat loss induced by central cholinergic stimulation during physical exercise. |
SAD, SHAM |
18 |
2009 |
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. |
ACh, AChE, AChEI, GAL, HBH, MWM |
19 |
2009 |
Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog. |
SCO |
20 |
2009 |
Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin. |
anti-ChE, AVP, ChE |
21 |
2007 |
Activation of the central cholinergic pathway increases post-exercise tail heat loss in rats. |
Tc |
22 |
2007 |
Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease. |
AD, APP, ChEI, PHE |
23 |
2007 |
Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice. |
--- |
24 |
2006 |
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. |
ACh, AChEI's, AD, GAL |
25 |
2006 |
Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor. |
ACh |
26 |
2005 |
A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model. |
AChE, Con A, PB, SRBC |
27 |
2005 |
Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent. |
MO, PG, SC |
28 |
2004 |
An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function. |
ACh, AChE, PB, PBMC |
29 |
2004 |
Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice. |
AChE, ASR, ChEI, i.p, PB, PPI |
30 |
2004 |
Intracerebroventricular physostigmine facilitates heat loss mechanisms in running rats. |
--- |
31 |
2003 |
Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. |
CZE, PYR |
32 |
2003 |
Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes. |
GAL |
33 |
2000 |
Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats. |
ACh, AChE, AD, BDF, DRH, DRL, HEP, OP |
34 |
2000 |
Nitrone spin trapping compound N-tert-butyl-alpha-phenylnitrone prevents seizures induced by anticholinesterases. |
AChE, DFP, IEG, KA, PBN, PIL, ROS |
35 |
2000 |
Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. |
SCO |
36 |
2000 |
Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. |
--- |
37 |
1999 |
Effects of cholinergic drugs on neocortical EEG and flash-visual evoked potentials in the mouse. |
EEG, FVEP, HEP |
38 |
1999 |
Physostigmine blocked nicotinic acetylcholine receptors in rat sympathetic ganglion neurons. |
nAChR, SCG |
39 |
1998 |
Development and in vivo assessment of a transdermal system for physostigmine. |
TD |
40 |
1998 |
Effects of physostigmine on the startle in guinea pigs: two mechanisms involved. |
SCO |
41 |
1998 |
Physiological, biochemical and histological changes due to physostigmine in monkeys. |
OP |
42 |
1998 |
Physostigmine and acetylcholine differentially activate nicotinic receptor subpopulations in Locusta migratoria neurons. |
ACh, nAChR |
43 |
1998 |
Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. |
SCO |
44 |
1997 |
Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. |
ACh |
45 |
1996 |
Acetylcholinesterase inhibitors block acetylcholine-evoked release of dopamine in rat striatum, in vivo. |
ACh, AChE-I, DA |
46 |
1996 |
Side effects of physostigmine as a pretreatment in guinea pigs. |
ChE |
47 |
1996 |
The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex. |
AD, APP, BETHA, ChE, ChEI, DDVP, HEP, TTX |
48 |
1995 |
Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. |
AD, APP, BETHA, ChE, ChEI, DDVP, HEP, TTX |
49 |
1995 |
Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo. |
ACh, ChEI, DA, HEP, IDA, NE |
50 |
1995 |
Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo. |
ACh, CLO, HEP, NE |
51 |
1995 |
Metabolic response to tacrine (THA) and physostigmine in the aged rat brain. |
LCGU |
52 |
1995 |
Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs. |
ChE |
53 |
1994 |
Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. |
ACh, HEP |
54 |
1994 |
Effect of AIT-082, a purine analog, on working memory in normal and aged mice. |
--- |
55 |
1994 |
Effect of concurrent exercise and physostigmine on lactate and pyruvate in plasma, muscle, and brain tissue of rats. |
AE, Phy-D |
56 |
1994 |
Oral administration of heptylphysostigmine in healthy volunteers: a preliminary study. |
ChE, HP, RBC |
57 |
1993 |
A novel agonist binding site on nicotinic acetylcholine receptors. |
alpha-BGT, BZQ, MLA, nAChRs |
58 |
1993 |
Cholinergic-opioid interactions at brainstem respiratory chemosensitive areas in cats. |
ACh, ATR, cVMS, mCSF |
59 |
1993 |
Concurrent acute exercise alters central and peripheral responses to physostigmine. |
ChE, RBC |
60 |
1993 |
Effect of physostigmine and exercise on choline acetyltransferase and acetylcholinesterase activities in fast and slow muscles of rat. |
AChE, ChAT, EDL |
61 |
1993 |
Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. |
nAChRs |
62 |
1993 |
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze. |
AChE |
63 |
1993 |
Physostigmine and neuromuscular transmission. |
ACh, nAChR |
64 |
1993 |
Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. |
AChE, MIA, PCA, RIT, SCOP, THA |
65 |
1992 |
Acetylcholinesterase inhibition and anti-soman efficacy of homologs of physostigmine. |
AChE, N-SAC |
66 |
1992 |
Age-dependent changes in serotonergic modulation of yawning in the rat. |
--- |
67 |
1992 |
Effect of physostigmine on plasma lactate and pyruvate in untrained/trained rats. |
AE, ET |
68 |
1992 |
Endurance training changes central and peripheral responses to physostigmine. |
AE, ChE, ET, RBC |
69 |
1992 |
Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL). |
AChE, HPTL |
70 |
1992 |
The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze. |
AChE, BChE, heptyl-Phy |
71 |
1991 |
Effect of 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta-(b)-quinoline monohydrate hydrochloride (NIK-247) on cholinergic enzyme activity in rats. |
ACh, ChAT, ChE, THA |
72 |
1991 |
Effect of cholinesterase inhibitor and exercise on choline acetyltransferase and acetylcholinesterase activities in rat brain regions. |
AChE, ChAT |
73 |
1991 |
Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. |
--- |
74 |
1990 |
Assessing the efficacy of azaprophen and physostigmine as a pretreatment for soman-induced incapacitation in guinea pigs by response-surface modeling. |
--- |
75 |
1990 |
Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. |
5-HIAA, ChE, DA, DOPAC, HVA, MTF, NA, THA |
76 |
1990 |
Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure. |
PYR |
77 |
1990 |
Extraction of physostigmine from biologic fluids and analysis by liquid chromatography with electrochemical detection. |
CSF, HPLC |
78 |
1989 |
Cholinergic regulation of arterial pressure by the C1 area of the rostral ventrolateral medulla. |
AP, CAT, HR, RVL, SNA |
79 |
1989 |
Comparing the response surfaces of two cholinolytics when used in combination with physostigmine as a pretreatment against organophosphate challenge. |
PRG, SCP |
80 |
1989 |
Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection. |
CSF |
81 |
1989 |
Determination of physostigmine in plasma by high-performance liquid chromatography and fluorescence detection. |
CV |
82 |
1989 |
In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissues of rats. |
--- |
83 |
1989 |
Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats. |
ChE, PYR |
84 |
1989 |
Modulation of acetylcholine release by nicotinic receptors in the rat brain. |
ACh, AChE, AD, i.c.v |
85 |
1989 |
Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration. |
BuChE, ChE |
86 |
1989 |
Physostigmine--an overview as pretreatment drug for organophosphate intoxication. |
ACh, BuChE, ChE |
87 |
1989 |
The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. |
ACh, AChE, AD, BuChE, ChE, ChEI |
88 |
1989 |
The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal efficacy against carbamate intoxication. |
2-PAM, AChE, CA, PR |
89 |
1988 |
A comparative study of the effects of four choline esters on the secretion of fluid and glycoprotein from rat submandibular glands. |
ACh, BET, CAR, GP, MET, SMG |
90 |
1988 |
Modulation of memory by post-training epinephrine: involvement of cholinergic mechanisms. |
EPI, IA, OTM, YMD |
91 |
1988 |
Role of cholinergic and GABAergic neuronal systems in cycloheximide-induced amnesia in mice. |
CXM, SDL |
92 |
1987 |
Action and localization of acetylcholine in the cat retina. |
ACh, ChAT, DBE, LY, SCO |
93 |
1987 |
Drug interaction for plasma protein binding: physostigmine and other drugs. |
--- |
94 |
1987 |
Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs. |
ChE |
95 |
1987 |
Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration. |
BuChE, ChE |
96 |
1986 |
Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration. |
BuChE |
97 |
1986 |
Hepatic and muscle clearance of physostigmine in the rat. |
Es |
98 |
1986 |
Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat. |
ACh, Ch, ChE, MO, ST |
99 |
1986 |
Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression? |
ACTH, CNS, DA, NE, PRL |
100 |
1986 |
The effects of physostigmine on acetylcholinesterase activity of CSF plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs. |
AChE, ChE, CSF, i.c.v, i.v |
|